Skip To Main Content
Graduate student working on Dell laptop

Explore degrees available through the No. 1 online graduate program in Texas. Study online to earn the same quality degree as on campus.

Two students working on equations on a white board with eligible text on it

Get information on the application process and funding opportunities for undergraduate, graduate and transfer students.

Ingenium blogger posing with fellow organization leaders with Aggie ring
Ingenium Our blog by students, for students

Get inspired by experiences and opportunities shared by fellow engineering students.

Students with thumbs up holding Future Aggie Engineers and Engineering Texas A&M University signs
PK-12 Outreach Spark!

Students and organizations can bring hands-on activities or design challenges to your location or just visit as guest speakers.

Female student views microscope view of cell on a computer screen
Dr. Shreya Raghavan's research involves creating tissue microenvironments that can mimic how the human body operates. This will allow clinicians to better understand how different treatments interact with inflammation in the intestines. | Image: Texas A&M Engineering

Gulf War Illness (GWI) is a multi-symptom illness that impacts an estimated 25% to 35% of veterans of the Gulf War. Since the war, functional gastrointestinal disorders related to GWI have gone largely unexplained and there are no clear therapies that directly address gastrointestinal dysfunction in GWI.

Dr. Shreya Raghavan, assistant professor in the Department of Biomedical Engineering at Texas A&M University, and her lab aim to develop new ways to research GWI occurrence and treatment options using bioengineering. 

“We believe that by investigating the pathobiology of GWI-related gastrointestinal dysfunction, we will be able to therapeutically target it and improve the quality of life of aging Gulf War veterans,” Raghavan said.

Her lab works on engineering tissue microenvironments for both intestinal inflammation research and cancer. By isolating all the individual cellular components and reengineering them in controlled ratios, the lab is able to better understand the different variables that cause the biological problems. These bioengineered constructs, if made from patient-derived cells, can then be used for personalized, patient-specific treatments.

“The readouts from bioengineered guts/intestines are phenomenally similar to comparable tissues from rodents, rabbits and even humans,” Raghavan said. “Our previous work has shown that by creating these gut structures, we’re able to compare physiological function and show remarkable equivalency.

Raghavan collaborates with Dr. Ashok Shetty, associate director of the Institute for Regenerative Medicine at Texas A&M. Raghavan’s research was recently funded by the Congressionally Directed Medical Research Program through their Gulf War Illness Research Program.

Female professor observes female student using pipette equipment in the lab.
Dr. Raghavan, right, said she is excited for the variety of applications her research could have, including chronic inflammatory diseases as well as cancer treatment. | Image: Texas A&M Engineering

One challenge her overall research faces is sourcing cell material from the patient to form the engineered portion. Many of the issues she’s trying to address impact only parts of the gut. 

“For a regenerative medicine approach to work, you have to show that other portions of the gut are still functioning normally,” Raghavan said. “That’s our first challenge — to show that engineered pieces from the uninvolved gut still function physiologically as expected and sourcing enough amounts of autologous tissue to create this solution.”

Raghavan said personal connections have also led to her interest in studying the gut, including family members afflicted with chronic gut disorders. She said engineers are problem solvers, and working as a biomedical engineer allows her to apply her training to diverse biology and medical questions.

“Even outside of GWI, this work has implications in other inflammatory disorders of the gut like Crohn’s and colitis, even cancer initiation,” Raghavan said. “These sorts of personalized medicine approaches are currently not very popular in the gut realm. It will be exciting to generate bioengineered guts, to ask so many different questions like, ‘Why are some patients susceptible to colorectal cancer? Or why do some individuals with inflammatory bowel disorders have disruptions in gut motility, and how can we treat them?’”